摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-Chlorophenyl)-1,2-oxazole-4-carboxamide

中文名称
——
中文别名
——
英文名称
3-(2-Chlorophenyl)-1,2-oxazole-4-carboxamide
英文别名
——
3-(2-Chlorophenyl)-1,2-oxazole-4-carboxamide化学式
CAS
——
化学式
C10H7ClN2O2
mdl
——
分子量
222.63
InChiKey
JACUYNPLZYQDKD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    69.1
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Process for the preparation of 2-thio penem derivatives and intermediates therefor
    申请人:BEECHAM GROUP PLC
    公开号:EP0046363A1
    公开(公告)日:1982-02-24
    The present invention provides a process for the preparation of a compound of the formula (IV): or salt or ester thereof wherein R1 and R2 are independently hydrogen; an organic radical bonded via a carbon atom to the ring carbon atom; a free, etherified or esterified hydroxy or mercapto group; an amino or acylamino group; or together R1 and R2 represent a group = CR5R6 wherein R5 and R6 are the same or different and each represent hydrogen or a hydrocarbon or heterocyclic group optionally substituted with a functional group; and R3 represents an organic radical; which process comprises reacting a compound of the formula (V): wherein Rx is hydrogen or a blocking group and R4 is an organic radical; with a thiol or reactive derivative thereof. The compounds of the formula (IV) are useful as antibiotics and [β-lactamase inhibitors, as are the compounds of the formula (V). This invention also provides the novel compounds of the formula (V) and certain novel compounds within formula (IV). Their preparation and use are described.
    本发明提供了一种制备式(IV)化合物或其盐或酯的工艺: 或其盐或酯 其中 R1 和 R2 独立地为氢;通过碳原子与环碳原子键合的有机基;游离的、醚化的或酯化的羟基或巯基;基或酰基;或 R1 和 R2 共同代表一个基团=CR5R6 其中 R5 和 R6 相同或不同,且各自代表氢或任选被官能团取代的烃基或杂环基;以及 R3 代表有机基;该工艺包括使式(V): 其中 Rx 是氢或封端基团,R4 是有机基团;与醇或其反应衍生物反应。式(IV)化合物可用作抗生素和[β-内酰胺酶抑制剂],式(V)化合物也可用作抗生素和[β-内酰胺酶抑制剂]。本发明还提供了新型的式 (V) 化合物和某些新型的式 (IV) 化合物。对它们的制备和用途进行了描述。
  • Beta-lactam antibiotics, their preparation and their use in pharmaceutical compositions
    申请人:BEECHAM GROUP PLC
    公开号:EP0028497A1
    公开(公告)日:1981-05-13
    The present invention provides the compounds of the formula (II): and pharmaceutically acceptable salts and esters thereof wherein R3 is a hydrogen atom, a group HO3S- or a group R5CO wherein R5 is C1-6 alkyl, C2-6 alkenyl, aryl, aryl(C1-6)alkyl or aryloxy(C1-6) alkyl; and R4 is an organic group other than methyl bonded to the -CO-NH-moiety via a carbon atom; with the proviso that when R3 is a hydrogen atom or a group R5CO the stereochemical configuration at the a-carbon atom of the C-6 substituent is S, and with the further proviso that when R' is a group HO2S- the hydrogen atoms at C-5 and C-6 are cis. Their use is described as are processes for their preparation. Compounds wherein the R'CO-moiety is replaced by a hydrogen atom are also prepared.
    本发明提供了式(II)化合物: 及其药学上可接受的盐和酯 其中 R3 是氢原子、基团 HO3S- 或基团 R5CO,其中 R5 是 C1-6 烷基、C2-6 烯基、芳基、芳基(C1-6)烷基或芳氧基(C1-6)烷基;以及 R4 是通过一个碳原子与-CO-NH-分子键合的除甲基以外的有机基团;但条件是,当 R3 是氢原子或基团 R5CO 时,C-6 取代基 a 碳原子上的立体化学构型为 S,而且当 R' 是基团 HO2S- 时,C-5 和 C-6 上的氢原子为顺式。本文介绍了这些化合物的用途及其制备工艺。还制备了 R'CO 原子被氢原子取代的化合物。
  • Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
    申请人:BEECHAM GROUP PLC
    公开号:EP0034443A2
    公开(公告)日:1981-08-26
    The present invention provides the compounds of the formula (II): and pharmaceutically acceptable salts and cleavable esters thereof wherein RCONH is an organic acylamino group and E is a carboxy group or pharmaceutically acceptable salt or ester thereof or is a cyano group. Their preparation is described as is their use in compositions containing them. Compounds wherein RCONH is replaced by an azido group are described as useful intermediates.
    本发明提供了式(II)化合物: 及其药学上可接受的盐和可裂解酯 其中 RCONH 是有机酰基,E 是羧基或其药学上可接受的盐或酯或基。本文介绍了它们的制备方法以及在含有它们的组合物中的用途。RCONH 被叠氮基团取代的化合物被描述为有用的中间体。
  • Modified beta-lactam compounds
    申请人:BEECHAM GROUP PLC
    公开号:EP0067518A1
    公开(公告)日:1982-12-22
    A 1-aza(3.2.0]bicycloheptan-2-carboxylic acid or salt or ester thereof having a substituent at position 7 of the formula: wherein R1 and R2 are independently hydrogen, halogen or an organic group.
    一种 1-氮杂(3.2.0]双环庚烷-2-羧酸或其盐或酯,在式中第 7 位有一个取代基: 其中 R1 和 R2 独立地为氢、卤素或有机基团。
  • Beta-lactam compounds, their preparation and their use
    申请人:BEECHAM GROUP PLC
    公开号:EP0073100A1
    公开(公告)日:1983-03-02
    A compound of formula (I): or a pharmaceutically acceptable salt or cleavable ester thereof, wherein RCONH- represents an organic acylamino group, and E is a carboxy group or a pharmaceutically acceptable salt or C,.,o alkyl or substituted C1-10 alkyl ester thereof or is a cyano group.
    式 (I) 的化合物:或其药学上可接受的盐或可裂解酯,其中 RCONH- 代表有机酰基,而 E 是羧基或其药学上可接受的盐或 C,.,o 烷基或取代的 C1-10 烷基酯或基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫